cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark
Authors:
- 12 March 2008
- journal article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 16 (8) , 935-940
Abstract
Calpainopathy or limb-girdle muscular dystrophy type 2A (LGMD2A) is generally recognized as the most prevalent form of recessive LGMD and is caused by mutations in the CAPN3 gene. Out of a cohort of 119 patients fulfilling clinical criteria for LGMD2, referred to our neuromuscular clinic, 46 were suspected to have LGMD2A, based on western blot results. Four of these patients were shown to have LGMD2I upon molecular analysis, whereas 16 of the remaining 42 patients harbored mutations in CAPN3 by both direct genomic sequencing and cDNA analyses. In 10 patients, we identified both mutant alleles. In three other, only one heterozygous mutation could be identified on the genomic level; however, CAPN3 cDNA analyses demonstrated homozygosity for the mutant allele, indicating the presence of an unidentified allele that somehow compromise correct CAPN3 RNA processing. In the three remaining patients, only a single heterozygous mutation could be identified both at the genomic level and on full-length CAPN3 cDNA. All three patients exhibited a highly abnormal western blot for calpain-3 and clinical characteristics of LGMD2A. Only three of the genetically confirmed LGMD2A patients were of Danish origin, indicating a five- to sixfold lower prevalence in Denmark compared to other European countries. A total of 16 different CAPN3 mutations were identified, of which 5 were novel. The present study demonstrates the value of cDNA analysis for CAPN3 in LGMD2A patients and indicates that calpainopathy is an uncommon cause of LGMD in the Denmark.Keywords
This publication has 31 references indexed in Scilit:
- Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2AJournal of Medical Genetics, 2007
- Calpain-3 mutations in TurkeyEuropean Journal of Pediatrics, 2006
- Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patientsMuscle & Nerve, 2005
- Calpains and DiseaseNew England Journal of Medicine, 2005
- The frequency of limb girdle muscular dystrophy 2A in northeastern ItalyNeuromuscular Disorders, 2005
- Novel mutations in the calpain 3 gene in GermanyClinical Genetics, 2005
- Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcomeNeuromuscular Disorders, 2004
- Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamicsNature Reviews Molecular Cell Biology, 2004
- Improved Splice Site Detection in GenieJournal of Computational Biology, 1997
- Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2ACell, 1995